Senseonics Holdings Inc (SENS) Sees Significant Decline in Short Interest
Senseonics Holdings Inc (NYSE:SENS) was the target of a significant drop in short interest in the month of September. As of September 29th, there was short interest totalling 3,455,069 shares, a drop of 10.8% from the September 15th total of 3,871,812 shares. Approximately 7.7% of the shares of the company are sold short. Based on an average trading volume of 805,360 shares, the short-interest ratio is currently 4.3 days.
Senseonics Holdings (NYSE SENS) opened at 3.14 on Wednesday. The firm has a 50-day moving average of $3.14 and a 200 day moving average of $3.14. Senseonics Holdings has a 52-week low of $2.15 and a 52-week high of $3.67. The company’s market capitalization is $386.85 million.
WARNING: This article was reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/10/11/senseonics-holdings-inc-sens-sees-significant-decline-in-short-interest.html.
About Senseonics Holdings
Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.
Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.